S&P 500 ^GSPC 5,306.04 +0.02%
Nvidia NVDA $1,140.59 +7.13%
Tesla TSLA $176.75 -1.39%
Alphabet GOOG $178.02 +0.96%
Amazon AMZN $182.15 +0.77%
Meta META $479.92 +0.36%
Microsoft MSFT $430.32 +0.04%
Apple AAPL $189.99 +0.01%

7 interesting stocks under $15 for Q2

Jamie Cameron
23. 4. 2024
4 min read

Are you familiar with these seven dynamic stocks priced under $15? These stocks are likely on the cusp of significant growth thanks to a wide range of innovative strategies across a variety of sectors. From financial technology and security payment solutions, to advanced pharmaceuticals and the energy industry, these companies demonstrate not only adaptability and resilience in dynamically changing market conditions, but also the ability to overcome economic challenges.

With their innovations and diverse ways of increasing revenues and strengthening market positions, new opportunities are opening up for investors seeking stability and potential for growth. These companies can offer exciting opportunities in areas that are key to the modern economy and demonstrate a strong commitment to long-term development and innovation.

SoFi Technologies, Inc. $SOFI

SoFi Technologies, originally focused on Lending, has expanded into other financial services, which has greatly diversified its revenue sources. As a result of this move, its reliance on the traditional lending segment has been significantly reduced. This strategy has yielded solid results, as the company reported revenue growth of 56 % to $871 million. This change demonstrates significant financial stability and strengthens SoFi's position in the financial technology space.

SOFI
$6.89 -$0.03 -0.43%
Capital Structure
Market Cap
7.3B
Enterpr. Val.
6.1B
Valuation
P/E
-23.8
P/S
3.1
Dividends
Yield
-
Payout
-11.4%

CompoSecure $CMPO

CompoSecure, a company specializing in security payment cards and technology solutions, has convincingly faced economic challenges, including inflation. Despite these challenges, the company has maintained a strong market position and reported in the fourth quarter of 2023 46% net profit growth compared to the prior year. The company thus demonstrates significant resilience and the ability to adapt to dynamically changing market conditions.

CMPO
$6.54 -$0.01 -0.15%
Capital Structure
Market Cap
527.1M
Enterpr. Val.
810.1M
Valuation
P/E
6.4
P/S
1.3
Dividends
Yield
4.6%
Payout
0.0%

VistaGen Therapeutics $VTGN-0.5%

VistaGen Therapeutics, focused on drug development for mental healthis preparing to initiate pivotal Phase 3 clinical trials of its lead drug, fasedienol, for the treatment of social anxiety disorder. The move could significantly shift the company's drug position. VistaGen is also engaged in the development of additional drugs, underscoring its commitment to innovation and expansion therapeutic options.

VTGN
$4.06 -$0.02 -0.49%
Capital Structure
Market Cap
109.7M
Enterpr. Val.
-14.3M
Valuation
P/E
-1.4
P/S
105.5
Dividends
Yield
-
Payout
-

Viant $DSP

Viant doing business in the field of of digital marketing, particularly in the world of Internet television (CTV). With its technology that enables targeted advertising without the need for cookies, Viant is strengthening its position. This innovative approach has contributed to ad spend on its platform accounting for roughly 40% of the company's total spend in Q4 2023. In addition, Viant has seen significant growth in clientele, particularly among mid-sized and large enterprises, demonstrating its ability to effectively respond to client needs.

DSP
$9.77 $0.15 +1.56%
Capital Structure
Market Cap
620.3M
Enterpr. Val.
442.2M
Valuation
P/E
-81.4
P/S
2.6
Dividends
Yield
-
Payout
-

SNDL $SNDL

SNDL, a company active in the field of manufacturing cannabis productsis going through a period of restructuring and improving its financial stability. Despite a significant operating loss of $162.8 million in 2023, SNDL was able to achieve this result significantly improved compared to the previous year's loss of $347.8 million. The company recorded an improvement of 53%, signalling solid progress towards financial turnaround. SNDL continues to reduce costs and improve operational efficiencies, which should lead to sustainable growth.

SNDL
$2.22 $0.00
Capital Structure
Market Cap
584.0M
Enterpr. Val.
766.2M
Valuation
P/E
-5.7
P/S
0.9
Dividends
Yield
-
Payout
-

Puma Biotechnology $PBYI

Puma Biotechnology, specialized in the development of innovative oncology drugs, has been growing steadily with slight fluctuations in its financial results. Revenues from sales of its lead product, NERLYNX, were stable at $203.1 million in 2023. The company also benefits from royalties, which contributes to further increase their revenues. Puma Biotechnology continues to strengthen its market position with its focus on innovation and its ability to develop drugs that have the potential to improve lives cancer patients.

PBYI
$4.02 $0.02 +0.50%
Capital Structure
Market Cap
193.9M
Enterpr. Val.
226.7M
Valuation
P/E
12.6
P/S
0.9
Dividends
Yield
-
Payout
-

Granite Ridge $GRNT-0.9%

Granite Ridge, operating in energy sector, is showing strong growth in oil and gas production. The company has achieved a 23% increase in total production to 24,311 barrels of oil equivalent (Boe) per day in 2023. With an effective exploration and production strategy, the company has been able to significantly increase its revenue and strengthen its competitiveness. With growing capacity and continued efficiency improvements of production operations, the company is profiling itself as a key player in the energy industry.

GRNT
$6.51 -$0.06 -0.91%
Capital Structure
Market Cap
851.1M
Enterpr. Val.
974.4M
Valuation
P/E
14.5
P/S
2.2
Dividends
Yield
6.7%
Payout
96.4%

Disclaimer: There is a lot of inspiration to be found on Bulios, but stock selection and portfolio construction is up to you, so always conduct a thorough analysis of your own.

Source.

Read the full article for free?
Go ahead 👇

Log in to Bulios

Log in and follow your favorite stocks, create a portfolio and discuss with others


Don't have an account? Join us

Pass the article on, or save it for later.